The phosphodiesterase 5 inhibitor sildenafil decreases the proinflammatory chemokine IL-8 in diabetic cardiomyopathy: in vivo and in vitro evidence.
J Endocrinol Invest
; 42(6): 715-725, 2019 Jun.
Article
in En
| MEDLINE
| ID: mdl-30415310
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Interleukin-8
/
Inflammation Mediators
/
Diabetic Cardiomyopathies
/
Phosphodiesterase 5 Inhibitors
/
Sildenafil Citrate
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Endocrinol Invest
Year:
2019
Document type:
Article
Affiliation country:
Italy
Country of publication:
Italy